Literature DB >> 23340174

Anti-apoptotic proteins on guard of melanoma cell survival.

Mariusz L Hartman1, Malgorzata Czyz.   

Abstract

Apoptosis plays a pivotal role in sustaining proper tissue development and homeostasis. Evading apoptosis by cancer cells is a part of their adaption to microenvironment and therapies. Cellular integrity is predominantly maintained by pro-survival members of Bcl-2 family and IAPs. Melanoma cells are characterized by a labile and stage-dependent phenotype. Pro-survival molecules can protect melanoma cells from apoptosis and mediate other processes, thus enhancing aggressive phenotype. The essential role of Bcl-2, Mcl-1, Bcl-X(L), livin, survivin and XIAP was implicated for melanoma, often in a tumor stage-dependent fashion. In this review, the current knowledge of pro-survival machinery in melanoma is discussed.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340174     DOI: 10.1016/j.canlet.2013.01.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  30 in total

Review 1.  Pro-survival role of MITF in melanoma.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  J Invest Dermatol       Date:  2014-08-21       Impact factor: 8.551

2.  Myeloid cell leukemia-1 is associated with tumor progression by inhibiting apoptosis and enhancing angiogenesis in colorectal cancer.

Authors:  Wan-Sik Lee; Young-Lan Park; Nuri Kim; Hyung-Hoon Oh; Dong-Jun Son; Mi-Young Kim; Chan-Young Oak; Cho-Yun Chung; Hyung-Chul Park; Jong-Sun Kim; Dae-Seong Myung; Sung-Bum Cho; Hyun-Soo Kim; Young-Eun Joo
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.

Authors:  E-W Lee; D Seong; J Seo; M Jeong; H-K Lee; J Song
Journal:  Cell Death Differ       Date:  2015-01-23       Impact factor: 15.828

Review 4.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

5.  Involvement of ER stress and activation of apoptotic pathways in fisetin induced cytotoxicity in human melanoma.

Authors:  Deeba N Syed; Rahul K Lall; Jean Christopher Chamcheu; Omar Haidar; Hasan Mukhtar
Journal:  Arch Biochem Biophys       Date:  2014-07-09       Impact factor: 4.013

6.  A small hairpin RNA targeting myeloid cell leukemia-1 enhances apoptosis in host macrophages infected with Mycobacterium tuberculosis.

Authors:  Fei-yu Wang; Yu-qing Zhang; Xin-min Wang; Chan Wang; Xiao-fang Wang; Jiang-dong Wu; Fang Wu; Wan-jiang Zhang; Le Zhang
Journal:  J Microbiol       Date:  2016-04-01       Impact factor: 3.422

7.  Gemcitabine nanoparticles promote antitumor immunity against melanoma.

Authors:  Yuan Zhang; Xin Bush; Bingfang Yan; Justin A Chen
Journal:  Biomaterials       Date:  2018-10-20       Impact factor: 12.479

8.  Expression of the apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence: correlations with pathology and outcome.

Authors:  Y Wang; Y Li; B Zhou; W Y Zhang; J T Guan; R Wang; L Yang; Q J Xia; Z G Zhou; X F Sun
Journal:  Tumour Biol       Date:  2014-10-23

9.  Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin.

Authors:  Niramol Savaraj; Chunjing Wu; Ying-Ying Li; Medhi Wangpaichitr; Min You; John Bomalaski; Wei He; Macus Tien Kuo; Lynn G Feun
Journal:  Oncotarget       Date:  2015-03-20

Review 10.  Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.

Authors:  Stuart J Gallagher; Jessamy C Tiffen; Peter Hersey
Journal:  Cancers (Basel)       Date:  2015-09-25       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.